2007 - 2017年丙型肝炎病毒感染患者与未感染患者的预期寿命
Life Expectancy of Insured People With and Without Hepatitis C Virus Infection, 2007-2017.
作者信息
Marcus Julia L, Hurley Leo B, Chamberland Scott, Champsi Jamila H, Korn Daniel G, Lai Jennifer B, Lam Jennifer O, Quesenberry Charles P, Ready Joanna, Saxena Varun, Seo Suk I, Witt David J, Silverberg Michael J
机构信息
Kaiser Permanente Division of Research, Oakland, California, USA.
Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
出版信息
Open Forum Infect Dis. 2020 Feb 5;7(2):ofaa044. doi: 10.1093/ofid/ofaa044. eCollection 2020 Feb.
Among 25 291 and 4 921 830 people with and without hepatitis C, life expectancy at age 20 increased 1.8 years and 0.3 years from the interferon to interferon-free era, respectively. Increases were highest for racial and/or ethnic minority groups with hepatitis C.
在25291名丙型肝炎患者和4921830名非丙型肝炎患者中，20岁时的预期寿命从干扰素时代到无干扰素时代分别增加了1.8岁和0.3岁。丙型肝炎患者中，种族和/或少数民族群体的预期寿命增加幅度最大。
Zotero 插件